Drug Information

General Information
Drug ID
DR00078
Drug Name
Valacyclovir
Synonyms
2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate; 2-{[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methyl]oxy}ethyl L-valinate; Acyclovir-valine; BW-256U; BW256U87; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester; L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9 H-purin-9-yl)methoxy]ethyl ester, monohydrochloride; TBB067866; Talavir; VACV; ValACV; Valaciclovir (INN); Valaciclovir Hcl; Valaciclovir [INN:BAN]; Valaciclovir, Valtrex; Valacyclover Hydrochloric; Valacyclover Hydrochloride; Valacyclovir; Valacyclovir, (L)-isomer; Valtrex; Valtrex (TN); Virval; Zelitrex; Zelitrex (TN)
Drug Type
Small molecular drug
Indication Herpes simplex virus infection [ICD11: 1F00] Approved [1]
Shingles [ICD11: 1.00E+91] Approved [1]
Therapeutic Class
Antiviral Agents
Structure
3D MOL 2D MOL
Formula
C13H20N6O4
Canonical SMILES
CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N
InChI
InChI=1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1
InChIKey
HDOVUKNUBWVHOX-QMMMGPOBSA-N
CAS Number
CAS 124832-27-5
Pharmaceutical Properties Molecular Weight 324.34 Topological Polar Surface Area 147
Heavy Atom Count 23 Rotatable Bond Count 8
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 7
XLogP
-0.9
PubChem CID
135398742
PubChem SID
103440109 , 104048282 , 104178841 , 104321602 , 117583422 , 118313436 , 12014356 , 124800881 , 126631789 , 126658129 , 126682447 , 128045545 , 131905333 , 134213320 , 134221757 , 134337933 , 135030189 , 135659820 , 137005923 , 137005924 , 142590832 , 14718342 , 14777186 , 14801572 , 14850688 , 14850689 , 14874889 , 15940044 , 160963922 , 162782405 , 163231563 , 163621098 , 29215498 , 43118121 , 46508197 , 47589092 , 48416691 , 50062212 , 56422581 , 57314102 , 626316 , 78076275 , 7980871 , 85279714 , 85789653 , 89736139 , 92309076 , 92710527 , 96025347 , 99775325
ChEBI ID
CHEBI:35854
TTD Drug ID
D04QJD
DT(s) Transporting This Drug ASCT2 Transporter Info Alanine/serine/cysteine/threonine transporter 2 Substrate [2]
OAT3 Transporter Info Organic anion transporter 3 Substrate [3]
PEPT1 Transporter Info Peptide transporter 1 Substrate [4]
PEPT2 Transporter Info Peptide transporter 2 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OAT3 Transporter Info Km = 57.9 microM Proximal tubule (S2) cells-OAT3 [3]
PEPT1 Transporter Info Km = 1640 microM Chinese hamster ovary (CHO) cells-PEPT1 [5]
PEPT1 Transporter Info Km = 2200 microM Chinese hamster ovary (CHO) cells-PEPT1 [6]
PEPT1 Transporter Info Km = 2700 microM Chinese hamster ovary (CHO) cells-PEPT1 [6]
PEPT1 Transporter Info Km = 5400 microM Chinese hamster ovary (CHO) cells-PEPT1 [6]
PEPT1 Transporter Info Km = 6600 microM Chinese hamster ovary (CHO) cells-PEPT1 [6]
PEPT1 Transporter Info Km = 7400 microM Chinese hamster ovary (CHO) cells-PEPT1 [6]
PEPT1 Transporter Info Km = 2.2 microM Chinese hamster ovary (CHO) cells-PEPT1 [7]
PEPT1 Transporter Info Km = 7.4 microM Chinese hamster ovary (CHO) cells-PEPT1 [7]
PEPT1 Transporter Info Km = 292 microM Human enterocyte-like 2 cells (Caco-2)-PEPT1 [8]
PEPT1 Transporter Info Km = 3.8 microM Madin-Darby canine kidney (MDCK) cells-PEPT1 [7]
PEPT1 Transporter Info Km = 5940 microM Oocytes-PEPT1 [9]
PEPT1 Transporter Info Km = 5.9 microM Xenopus oocytes-PEPT1 [7]
References
1 Acyclovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport of amino acid-based prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J Pharmacol Exp Ther. 2004 Mar;308(3):1138-47.
3 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
4 Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun. 1998 May 19;246(2):470-5.
5 Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. J Pharmacol Exp Ther. 1999 Apr;289(1):448-54.
6 Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells. Biopharm Drug Dispos. 2000 Jul;21(5):165-74.
7 Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice. Drug Metab Dispos. 2013 Mar;41(3):608-14.
8 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res. 1998 Aug;15(8):1154-9.
9 Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun. 1998 Sep 18;250(2):246-51.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.